Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) [Phase 1]
Phase 1 trial update of belzutifan (PT2977, MK-6482) in patients with advanced solid tumors; study status is Phase 1 and not recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM [Phase 1]
Phase 1 trial evaluating IL13Ra2-CAR T cells with or without nivolumab and ipilimumab in recurrent glioblastoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors [Phase 1, Phase 2]
A pharmacokinetic study evaluating the combination of lurbinectedin and irinotecan in selected solid tumors has completed (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Loupe-Based Intraoperative Fluorescence Imaging
Clinical trial update on loupe-based intraoperative fluorescence imaging for brain tumors; recruitment is ongoing for glioblastoma and anapl…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: BC008-1A Injection for Recurrent CNS WHO G4 Glioma [Phase 1]
A Phase 1 study of BC008-1A Injection for recurrent central nervous system WHO Grade 4 glioma (including glioblastoma) is currently recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Restrictive Use of Dexamethasone in Glioblastoma [NA]
This clinical trial update notes a study evaluating the restrictive use of dexamethasone in glioblastoma patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels
This completed clinical trial evaluates BIOhabitats and biologically validates vascular habitats within Grade 4 astrocytoma (glioblastoma) a…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
A multicentre study validates vascular biomarkers from tumors as predictors of survival in glioblastoma. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas
The ALBATROSS international multicenter study completed its prospective validation of imaging biomarkers calculated at vascular habitats of …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
This prospective observational study investigates whether olfactory function can serve as a prognostic indicator in adults with glioblastoma…
-
CLINICAL_TRIALS withdrawal · 2025-07-08Clinical Trial Update: Role of Repeat Resection in Recurrent Glioblastoma [NA]
The clinical trial evaluating repeat resection for recurrent glioblastoma has been withdrawn (status: WITHDRAWN).
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Trial of C134 in Patients With Recurrent GBM [Phase 1]
Phase 1 clinical trial update for C134 in recurrent glioblastoma and related brain cancers reports results with results posted on 2025-07-03…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma [NA]
This Columbia University trial assesses adaptive radiotherapy guided by MRI for adults with newly diagnosed high-grade glioma, including gli…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma [Phase 2]
Phase II clinical study assessing the efficacy and safety of combining flazoparib with temozolomide after standard chemoradiotherapy in newl…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial of a neoantigen-specific adoptive T cell therapy for newly diagnosed MGMT-negative glioblastoma multiforme, spons…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
This clinical trial update indicates that the study evaluating genomic, histologic, and radiomic analysis of regional tumor heterogeneity in…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma [Phase 1]
Phase 1 clinical trial evaluating mycophenolate mofetil in combination with radiation therapy for glioblastoma and related astrocytomas; the…
-
CLINICAL_TRIALS other · 2025-06-29Clinical Trial Update: Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1]
Phase 1 trial evaluating nivolumab in combination with BMS-986205 and radiation therapy, with or without temozolomide, for newly diagnosed g…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Temozolomide Chronotherapy for High Grade Glioma [Phase 2]
Phase 2 trial of temozolomide chronotherapy for high-grade glioma, including glioblastoma, has completed with results posted.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating APL-101 in non-small cell lung cancer with MET exon 14 skipping mutations and MET dysregulation, as well as other M…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma [Phase 1]
This is a Phase 1 clinical trial evaluating intracranial TGFβR2KO/IL13Rα2 CAR T-cells for recurrent glioblastoma and IDH-mutant astrocytoma …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma [Phase 1]
Phase 1 clinical trial update evaluating intrathecal azacitidine in combination with nivolumab for recurrent high-grade glioma. The study is…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM [Phase 2]
This Phase 2 clinical trial investigates metformin with neoadjuvant temozolomide and hypo-accelerated radiotherapy followed by adjuvant temo…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating irradiation with olaptesed pegol (NOX-A12) in MGMT unmethylated glioblastoma; the study is currently active…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma [Phase 1]
Phase 1 trial evaluating the combination of eflornithine and temozolomide in newly diagnosed glioblastoma or astrocytoma; recruitment is ong…